鹅细小病毒VP1-VP3非重叠区基因的克隆与序列分析

通过克隆鹅细小病毒(Goose parvovirus,GPV)分离株VP1-V3非重叠区基因,并对其进行序列分析,为鹅细小病毒感染与疫苗免疫的鉴别诊断奠定理论基础.进行鹅胚病毒增殖,收集尿囊液,提取基因组,参考发表的B株序列,设计合成一对引物,经PCR扩增,克隆VP1-VP3基因,筛选阳性克隆,对其进行序列测定及同源性分析.结果表明,克隆的基因片段为901 bp,VP1-VP3基因共594 bp,编码198个氨基酸;弱毒株之间亲缘关系很近,核苷酸同源性99.5％～100％,氨基酸同源性98.5％～100％;强毒株与B株亲缘关系较近,核苷酸同源性96.6％,氨基酸同源性97.5％;弱毒株与强毒株亲缘关系较远,核苷酸同源性92％～93％,氨基酸同源性96％～97.5％;弱毒株与B株亲缘关系最远,核苷酸同源性92.5％～93％,氨基酸同源性93.9％～95.5％.说明强毒株与弱毒株之间核苷酸序列存在差异.     

鹅细小病毒基因组结构特征研究进展

鹅细小病毒（Goose parvovirus,GPV）属细小病毒科,细小病毒属,由我国学者方定一1956年首次分离报道。GPV基因组约5 Kb,由左右2个完整的开放阅读框（open reading frame,ORF）组成：LORF（left ORF）和RORF（right ORF）。LORF编码非结构蛋白（nonstructural protein,NS）NS1和NS2,RORF编码VP1、VP2和VP3三种结构蛋白。本文针对近年来鹅细小病毒基因组结构特征的研究进展进行了综述。     

联合肌注猪IL2真核质粒对PPV VP2-PCV2 ORF2核酸疫苗免疫效果的影响

将猪IL2基因和PPV VP2基因、PCV2 ORF2截短基因克隆至真核表达载体pCI-neo,构建了重组质粒pCI-ORF2-VP2和pCI-IL2,用脂质体介导法将pCI-ORF2-VP2质粒转染PK15细胞,采用间接免疫荧光法检测在体外的表达情况。并以小鼠为动物模型,将pCI-IL2和pCI-ORF2-VP2质粒联合肌注免疫小鼠,相同剂量免疫2次,间隔2周,同时设立pCI-ORF2-VP2、pCI空载体、猪细小灭活苗、圆环亚单位苗对照,检测免疫小鼠脾脏淋巴细胞的转化功能,外周血T淋巴细胞亚群的动态变化及血清抗体的滴度。结果显示,pCI-ORF2-VP2在PK15细胞中能正常表达,联合免疫组在第28天能够检测到PPV和PCV2抗体,第21~42天诱导淋巴细胞转化和CD4+、CD8+细胞的数量高于或显著高于pCI-ORF2-VP2质粒组。结果表明,猪IL2质粒联合肌注可以提高VP2/ORF2核酸疫苗的免疫效果。     

Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein

The major structural protein VP2 of porcine parvovirus (PPV) was used as the model parvovirus antigen, which has been expressed in Lactobacillus casei fusing with Escherichia coli heat-labile enterotoxin B subunit (LTB) as mucosal adjuvant. The VP2-LTB DNA fragment was cloned into vector pPG611 or pPG612 to generated inducible surface-displayed and secretion expression systems based on xylose promoter, designated as rLc:pPG611-VP2-LTB (recombinant L. casei) and rLc:pPG612-VP2-LTB, respectively. Expression of the fusion protein was verified by SDS-PAGE, Western blot immunofluorescence and electron microscopy. It was observed that the level of IgG or sIgA from mice orally immunized with VP2-LTB was higher than that from mice received VP2 and negative control, which demonstrated significantly statistically different. Especially, the titer of IgG or sIgA in mice immunized with rLc:pPG612-VP2-LTB is the highest in this study. In summary, LTB as mucosal adjuvant was able to effectively facilitate induction of mucosal and systemic immunity by L. casei-expressing VP2 fusion protein.     

Validation of an ELISA method for the serological diagnosis of canine brucellosis due to Brucella canis

In the present study, the validation of an enzyme-linked immunosorbent assay (ELISA) for serodiagnosis of canine brucellosis is described. Two different antigenic extracts, obtained by heat or ultrasonic homogenization of microbial antigens from a wild isolate of Brucella canis bacteria, were compared by ELISA and Western blot (WB). A total of 145 canine sera were used to define sensitivity, specificity and accuracy of the ELISA as follows: (1) sera from 34 animals with natural B. canis infection, confirmed by blood culture and PCR, as well as 51 sera samples from healthy dogs with negative results by the agar–gel immunodiffusion (AGID) test for canine brucellosis, were used as the control panel for B. canis infection; and (2) to scrutinize the possibility of cross reactions with other common dog infections in the same geographical area in Brazil, 60 sera samples from dogs harboring known infections by Leptospira sp., Ehrlichia canis, canine distemper virus (CDV), Neospora caninum, Babesia canis and Leishmania chagasi (10 in each group) were included in the study. The ELISA using heat soluble bacterial extract (HE-antigen) as antigen showed the best values of sensitivity (91.18%), specificity (100%) and accuracy (96.47%). In the WB analyses, the HE-antigen showed no cross-reactivity with sera from dogs with different infections, while the B. canis sonicate had various protein bands identified by those sera. The performance of the ELISA standardized with the heat soluble B. canis antigen indicates that this assay can be used as a reliable and practical method to confirm infection by this microorganism, as well as a tool for seroepidemiological studies.     

环介导等温扩增技术快速检测猪细小病毒的试验

利用环介导等温核酸扩增技术(LAMP),建立了一种灵敏、特异、快速的猪细小病毒(PPV)检测方法.该方法针对猪细小病毒非结构蛋白(NS-1)基因保守区域设计6条特异引物,在63℃的等温条件下45 min即可完成反应.最低检测限量为10拷贝的PPV目的基因,比常规聚合酶链式反应(PCR)方法敏感100倍,并具有良好的特异性.以钙黄绿素和Mn2+作为荧光指示剂,可快速、直观判定反应结果.通过对149份临床样品进行检测比较,LAMP与PCR检出阳性样本数分别为33份和27份,表明LAMP方法阳性检出率高于PCR.     

犬细小病毒的病例分析

为了解西安地区犬细小病毒感染的流行病学和临床诊疗情况,给该病的防制提供科学依据,对一年期间前来西北农林科技大学西安宠物医院就诊的70例犬细小病毒感染病例进行了临床调查研究,并对部分病例诊疗过程中的血液白细胞变化进行了监测.西安地区犬细小病毒感染一年四季均可发生,以深秋和冬春季多发;感染犬以7周龄～6月龄的断奶犬最多;感...     

鹅细小病毒强毒YBLJ分离株的分离鉴定与vp3基因的进化分析

为分离鹅细小病毒(GPV),本研究将疑似GPV感染鹅的组织样品接种SPF鹅胚进行病毒分离和鉴定.结果显示,第4代病毒对12日龄鹅胚的平均致死时间为96 h,ELD50为10-4.6/0.5 mL,PCR和琼脂扩散试验均呈GPV阳性反应,负染电镜下可观察到直径20 nm～25 nm的圆形或六角形病毒粒子,病毒可以被GPV标准阳性血清完全中和,回归雏鹅后表现典型的GP临床症状和特征性病理变化,发病率和致死率均为100％.分离株GPV的vp3基因全长1 605 bp,编码534个氨基酸,与国内外有代表性11株GPVvp3基因的核苷酸同源性为94％～98％,氨基酸同源性为96％～99％.将该分离病毒命名为GPVYBLJ分离株.     

番鸭源小鹅瘟病毒PT株VP基因的克隆与序列分析

为了获得番鸭(Cairina moschata)源小鹅瘟病毒(Goose parvovirus,GPV)结构蛋白VP基因的相关信息,根据国内外已发表鹅源GPV与番鸭细小病毒(Muscovy duck parvovirus,MDPV)全基因序列,应用DNAStar分子生物学软件设计一对引物,应用高保真PCR技术扩增番鸭源小鹅瘟病毒PT株(GPV PT株)VP全基因序列.将扩增得到的VP全基因克隆到pMD 18-T载体上,获得的重组质粒经PCR鉴定后进行序列测定.结果表明,PT株VP全基因大小为2 199 bp,编码732个氨基酸(GenBank登录号:JF926695),与番鸭源小鹅瘟病毒GPV DY株核苷酸及其推导氨基酸同源性分别为98.8％和98.8％,高于鹅源GPV与MDPV参考毒株.在国内外首次发现番鸭源GPV VP基因VP1独特区具有MDPV核苷酸序列特征,而VP2基因具有鹅源GPV核苷酸序列特征.本研究从番鸭源GPV PT株成功克隆到结构蛋白全基因序列,为深入研究番鸭源GPV的起源及水禽细小病毒遗传衍化提供参考.     

石河子地区犬细小病毒野毒株的PCR检测与遗传变异初步研究

为探索石河子地区的CPV野毒株是否发生遗传变异,本试验收集石河子地区自然发病犬及病死犬的粪便和组织,提取其病毒基因组,利用PCR技术对犬细小病毒VP2基因片段进行扩增,对扩增片段进行克隆和测序,并与不同地域流行株VP2基因进行比对,分析其差异。结果显示,本试验成功克隆了VP2基因,且序列分析结果显示一毒株存在14个点突变位点其和5个缺失位点,另一毒株存在7个突变位点。经基因型鉴定,野毒株的基因型均为CPV-2a型。